Bloodstram Infections in ICU. Single Centre Observational Study.

Sponsor
Military Institute of Medicine, Poland (Other)
Overall Status
Completed
CT.gov ID
NCT04926935
Collaborator
(none)
3,502
1
156
22.5

Study Details

Study Description

Brief Summary

Hospital-acquired bloodstream infection (BSI) is serious care problem worldwide associated with significant morbidity and mortality. However, only few nationwide studies have focused on the incidence of BSI, and its results were often inconsistent.

The objective of this study was to analyze bloodstream infections in patients hospitalized in the intensive care unit of the tertiary, university hospital. Special attention was put on the etiology of the infections, the antimicrobial susceptibility/resistance of the isolated pathogens, as well as the incidence of central vein catheters infections in the analyzed population.

Data were collected in the intensive care unit of the Military Institute of Medicine, Warsaw, Poland, between January, 1, 2007 and December, 31, 2019.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Microbiological analysis of blood samples.

Study Design

Study Type:
Observational
Actual Enrollment :
3502 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Bloodstram Infections in Intensive Care Unit. A Single Centre Bacteriological Analysis Between 2007-2019.
Actual Study Start Date :
Jan 1, 2007
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Patients hospitalized in the ICU during the study period.

Patients hospitalized in the ICU during the study period with clinically suspected infection.

Diagnostic Test: Microbiological analysis of blood samples.
Microbiological analysis of blood samples collected from the patients with clinically suspected infection.

Outcome Measures

Primary Outcome Measures

  1. Results of microbiological analysis. [After completion of the microbiological analysis, up to 72 hours.]

    Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.

  2. Isolated pathogens' susceptibility for antimicrobial agents. . [After completion of the microbiological analysis, up to 72 hours.]

    Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.

  3. Isolated pathogens' resistance for antimicrobial agents. . [After completion of the microbiological analysis, up to 72 hours.]

    Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all patients hospitalized in the ICU with clinically suspected infection.
Exclusion Criteria:
  • none.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Anesthesiology and Intensive Therapy Warsaw Poland 04-141

Sponsors and Collaborators

  • Military Institute of Medicine, Poland

Investigators

  • Principal Investigator: Dariusz Tomaszewski, MD, PhD, Military Institute of Medicine, Poland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dariusz Tomaszewski, Associate Professor, Military Institute of Medicine, Poland
ClinicalTrials.gov Identifier:
NCT04926935
Other Study ID Numbers:
  • 09
First Posted:
Jun 15, 2021
Last Update Posted:
Jun 15, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2021